Uncategorized

A New Jersey Hospital Network Just Became the First in the US Certified for ‘Responsible’ AI Use

Hackensack Meridian Health has become the first U.S. health system to earn the Joint Commission's Responsible Use of AI in Healthcare certification, a new credential evaluating governance, bias reduction, and transparency around hospital AI tools.

aidatanews

On July 29, 2026, Hackensack Meridian Health announced it had become the first health system in the country to earn the Joint Commission’s Responsible Use of AI in Healthcare (RUAIH) Certification, a new voluntary credential the accrediting body launched only months earlier to formally evaluate how hospitals govern the AI tools already running inside their walls. For a network that operates 18 hospitals and hundreds of outpatient sites across New Jersey, the certification marks less a single new product launch and more a public accounting of years of internal rule-making around when and how algorithms get to touch patient care.

What the Certification Actually Checks

The Joint Commission built the RUAIH standard around six domains: governance and oversight, patient privacy and data safeguards, identification and reduction of bias, ongoing safety monitoring, transparency toward patients, and staff training. Rather than certifying any specific AI product, surveyors examined Hackensack Meridian’s internal processes for vetting, deploying, and auditing whatever AI tools its clinicians and administrators use, from documentation assistants to predictive risk scores embedded in the electronic health record. Ken Grubbs, the Joint Commission’s chief nursing executive, said organizations pursuing the credential must show their AI use “is guided by strong governance, rigorous oversight, and an unwavering focus on patient safety,” language that reflects the accreditor’s broader worry that hospitals are adopting AI faster than they are building the guardrails around it.

Why Hackensack Meridian Pursued It Now

Robert C. Garrett, the health system’s president and CEO, framed the certification as a response to AI’s dual potential to help and to harm if left unmanaged, saying the technology can help “detect diseases earlier, personalize treatment for every patient, improve the efficiency of our hospitals, and reduce administrative work that contributes to burnout” when governed well. Joel Klein, the system’s chief digital and information officer, struck a similar note, arguing that AI’s purpose in medicine “is not to replace the human side of medicine, but to strengthen it.” Both statements point to a system trying to get ahead of a credentialing wave that health systems increasingly expect payers, regulators, and patients to start asking about.

The Regulatory Backdrop

The certification arrives as oversight of health AI is shifting in two directions at once. The FDA, which regulates AI embedded in diagnostic and treatment devices, loosened its stance on some low-risk wearables and wellness software in January 2026, saying tools that let clinicians independently review recommendations don’t need premarket review. But the vast majority of AI now used inside hospitals, things like ambient documentation, staffing predictions, and risk-scoring dashboards, was never FDA-regulated to begin with, because it doesn’t meet the legal definition of a medical device. The Joint Commission’s RUAIH certification effectively fills that gap, giving hospitals a formal, third-party seal for the AI governance work that federal regulators have no jurisdiction over.

A Broader Industry Reckoning

Surveys of hospital AI adoption have found that roughly a third of U.S. hospitals now report using generative AI in some clinical or administrative function, a figure that has climbed steadily since 2023 but has outpaced the development of formal oversight structures at most institutions. Health policy researchers have warned for several years that algorithms trained on incomplete or skewed data can quietly worsen racial and economic disparities in care even when they perform well on paper, which is part of why bias identification and reduction became one of the six pillars the Joint Commission chose to evaluate. Hackensack Meridian’s certification is likely to be watched closely by peer systems weighing whether to pursue the same credential, both as a competitive differentiator and as a hedge against future regulation.

What Comes Next

The Joint Commission has said it expects more health systems to apply for RUAIH certification over the coming year as the standard matures, and industry observers expect it to eventually factor into how insurers and large employers evaluate hospital partners. For now, Hackensack Meridian’s distinction is a first, not a final word: the certification does not freeze the system’s AI governance in place, and the Joint Commission will require ongoing monitoring and periodic reassessment to keep the credential active. The real test, health policy analysts say, will be whether formal governance structures like these actually change outcomes for patients, or whether they mostly formalize practices hospitals were already following informally.